Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BLFS NASDAQ:INMD NASDAQ:MDXG NASDAQ:NNOX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLFSBioLife Solutions$21.91-2.9%$22.45$18.70▼$29.55$1.04B1.79420,408 shs92,783 shsINMDInMode$15.01-2.3%$14.36$13.14▼$19.85$948.15M1.951.22 million shs244,880 shsMDXGMiMedx Group$6.91-1.3%$6.50$5.47▼$10.14$1.03B1.76681,763 shs95,105 shsNNOXNano-X Imaging$5.15-1.6%$5.24$3.75▼$11.00$296.70M1.961.74 million shs278,679 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLFSBioLife Solutions+3.39%+4.11%-4.89%-1.05%+10.27%INMDInMode+1.72%+3.57%+8.47%-0.65%-11.77%MDXGMiMedx Group+8.02%+12.54%+7.86%-2.23%+2.79%NNOXNano-X Imaging+2.15%+2.35%-5.42%+15.96%-27.06%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBLFSBioLife Solutions3.1025 of 5 stars3.53.00.00.02.62.50.6INMDInMode3.3132 of 5 stars3.13.00.00.03.11.71.9MDXGMiMedx Group3.4135 of 5 stars3.53.00.00.00.63.31.9NNOXNano-X Imaging1.324 of 5 stars3.52.00.00.00.00.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLFSBioLife Solutions 3.00Buy$31.1742.28% UpsideINMDInMode 2.13Hold$18.5423.54% UpsideMDXGMiMedx Group 3.00Buy$12.5080.87% UpsideNNOXNano-X Imaging 3.00Buy$9.5084.65% UpsideCurrent Analyst Ratings BreakdownLatest NNOX, INMD, BLFS, and MDXG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/6/2025NNOXNano-X ImagingD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$10.005/23/2025NNOXNano-X ImagingD. Boral CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$15.00 ➝ $10.005/22/2025NNOXNano-X ImagingAlliance Global PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy5/13/2025BLFSBioLife SolutionsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$30.00 ➝ $30.004/30/2025INMDInModeBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$29.00 ➝ $24.004/29/2025INMDInModeUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$19.00 ➝ $16.254/29/2025INMDInModeCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$17.00 ➝ $15.004/29/2025INMDInModeBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral4/28/2025INMDInModeBaird R WSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold4/28/2025INMDInModeRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOutperform ➝ Neutral$22.00 ➝ $16.004/28/2025INMDInModeNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold(Data available from 7/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLFSBioLife Solutions$82.25M12.65$0.12 per share178.02$7.52 per share2.91INMDInMode$394.82M2.40$1.81 per share8.28$10.12 per share1.48MDXGMiMedx Group$348.88M2.93$0.35 per share19.56$1.31 per share5.28NNOXNano-X Imaging$11.28M26.35N/AN/A$3.27 per share1.57Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLFSBioLife Solutions-$20.18M-$0.29N/AN/AN/A-11.81%-0.66%-0.58%8/14/2025 (Estimated)INMDInMode$181.27M$2.336.448.25N/A44.79%17.17%15.20%7/30/2025 (Estimated)MDXGMiMedx Group$42.42M$0.2725.7621.60N/A11.40%22.70%16.77%7/30/2025 (Estimated)NNOXNano-X Imaging-$53.52M-$0.90N/AN/AN/A-472.19%-30.92%-27.73%8/19/2025 (Estimated)Latest NNOX, INMD, BLFS, and MDXG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/30/2025Q2 2025MDXGMiMedx Group$0.06N/AN/AN/A$90.79 millionN/A5/22/2025Q1 2025NNOXNano-X Imaging-$0.23-$0.21+$0.02-$0.21$3.98 million$3.00 million5/8/2025Q1 2025BLFSBioLife Solutions-$0.03$0.04+$0.07-$0.01$22.22 million$23.94 million4/30/2025Q1 2025MDXGMiMedx Group$0.06$0.06N/A$0.05$86.32 million$88.21 million4/28/2025Q1 2025INMDInMode$0.45$0.31-$0.14$0.26$82.21 million$77.87 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLFSBioLife SolutionsN/AN/AN/AN/AN/AINMDInModeN/AN/AN/AN/AN/AMDXGMiMedx GroupN/AN/AN/AN/AN/ANNOXNano-X ImagingN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLFSBioLife Solutions0.014.733.74INMDInModeN/A8.737.86MDXGMiMedx Group0.094.704.13NNOXNano-X ImagingN/A5.305.16Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLFSBioLife Solutions93.24%INMDInMode68.04%MDXGMiMedx Group79.15%NNOXNano-X Imaging21.49%Insider OwnershipCompanyInsider OwnershipBLFSBioLife Solutions2.20%INMDInMode6.92%MDXGMiMedx Group1.70%NNOXNano-X ImagingN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBLFSBioLife Solutions44047.50 million46.46 millionOptionableINMDInMode48063.21 million58.84 millionOptionableMDXGMiMedx Group870147.70 million145.19 millionOptionableNNOXNano-X Imaging19057.78 millionN/AOptionableNNOX, INMD, BLFS, and MDXG HeadlinesRecent News About These CompaniesNanox Announces Clinical and Educational Collaboration with Keiser University Featuring the Nanox.ARCJuly 1, 2025 | globenewswire.comCantor Fitzgerald Predicts Nano-X Imaging FY2026 EarningsJune 11, 2025 | marketbeat.comNanox Imaging to Present at the Investor Summit Virtual on June 10, 2025June 9, 2025 | accessnewswire.comANanox Receives MDR CE Mark for HealthOST, an Advanced AI-Powered Software for Spine AssessmentJune 5, 2025 | globenewswire.comNanox to Participate in Sidoti Small Cap ConferenceJune 3, 2025 | globenewswire.comWhat Does The Future Hold For Nano-X Imaging Ltd. (NASDAQ:NNOX)? These Analysts Have Been Cutting Their EstimatesMay 27, 2025 | finance.yahoo.comNano-X Imaging Ltd. (NASDAQ:NNOX) Q1 2025 Earnings Call TranscriptMay 24, 2025 | insidermonkey.comNano-X Imaging price target lowered to $7 from $9 at Alliance Global PartnersMay 23, 2025 | finance.yahoo.comNano X Imaging Ltd (NNOX) Q1 2025: Everything You Need To Know Ahead Of EarningsMay 23, 2025 | finance.yahoo.comNano-X Imaging Reports Q1 2025 Financial Results and GrowthMay 22, 2025 | tipranks.comNano-X Imaging Ltd. Earnings Call: Growth Amid ChallengesMay 22, 2025 | tipranks.comNano-X Imaging Ltd. (NNOX) Q1 2025 Earnings Call TranscriptMay 22, 2025 | seekingalpha.comNanox Announces First Quarter 2025 Financial Results and Provides Business UpdatesMay 22, 2025 | finance.yahoo.comNano-X Imaging: Still Too Early To InvestMay 9, 2025 | seekingalpha.comNanox to Report First Quarter 2025 Financial Results on May 22, 2025May 8, 2025 | globenewswire.comNanox New Imaging System Receives FDA ClearanceApril 21, 2025 | finance.yahoo.comNano X Imaging Ltd (NNOX) Q4 2024 Earnings Call Highlights: Navigating Growth Amidst Financial ...April 21, 2025 | finance.yahoo.comNano-X Imaging receives FDA clearance for general use of Nanox.ARC XApril 17, 2025 | markets.businessinsider.comNanox Climbs on Releasing Imaging SystemApril 17, 2025 | baystreet.caWhy Nano-X Imaging Stock Soared TodayApril 17, 2025 | fool.comNanox Receives FDA Clearance for General Use of New Imaging System, Nanox.ARC XApril 17, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNNOX, INMD, BLFS, and MDXG Company DescriptionsBioLife Solutions NASDAQ:BLFS$21.90 -0.65 (-2.86%) As of 11:23 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.InMode NASDAQ:INMD$15.01 -0.35 (-2.29%) As of 11:23 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.MiMedx Group NASDAQ:MDXG$6.91 -0.09 (-1.27%) As of 11:23 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company's products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia.Nano-X Imaging NASDAQ:NNOX$5.14 -0.09 (-1.63%) As of 11:23 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Amazon's Prime Day Pullback Meets Bullish Golden Cross Signal Palantir’s Revenue Surge to $1B: Growth vs. Valuation Chime Financial: Analysts Ring In—And It’s a Buy Is Fortinet Ready to Break Out After Months of Consolidation? AST SpaceMobile: Is Market Noise Drowning Out a $100M Signal? CoreWeave's $9 Billion Power Play for Core Scientific Taiwan Semiconductor May Profit from Chinese Manufacturing Issues Micron Insiders Sell But Investors Should Buy, Buy, Buy Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
